QDEL Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 23, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for QuidelOrtho Corp (QDEL)

Based on 14 analysts giving stock ratings to QuidelOrtho Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
21
Buy
36
Hold
36
Sell
7
Strong Sell
0
QuidelOrtho Corp

QuidelOrtho Corp. Stock Analysis QDEL

United States Health Care Small Cap Report:
QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,500 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Read More

QuidelOrtho Corp (QDEL) Chart

Key Statistics of QuidelOrtho Corp (QDEL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$10.31$11.54

Today's Open

$11.39

Volume

2.45M

P/E Ratio (TTM)

-

52 Week Range

$9.92$35.58

Market Cap

793.83M

Avg. Volume

3.05M

Dividend Yield

-

Financial Metrics & Statements of QuidelOrtho Corp (QDEL)

FAQ's for QuidelOrtho Corp (QDEL)

  • According to Musaffa’s Shariah screening methodology, QuidelOrtho Corp (QDEL) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.